Full-Time

Principal Software Engineer

Salesforce

Updated on 8/11/2026

Deadline 8/22/26
Aflac

Aflac

10,001+ employees

Supplemental health and life insurance provider

Compensation Overview

$123k - $170k/yr

+ Annual bonus + Company stock purchase opportunity

Remote in USA + 2 more

More locations: Columbus, GA, USA | Columbia, SC, USA

Hybrid

Remote work is within the continental United States; remote employees may occasionally be asked to visit an office. Within 50 miles of Columbus, GA or Columbia, SC requires at least 60% in-office work.

Bachelor's, Master's

Category
Software Engineering (1)
Required Skills
Mainframe Computing
Salesforce
SCRUM
DevOps

Get referred to Aflac

See people who can refer or advise you

Requirements
  • Deep experience with modern programming languages and cloud development.
  • Mastery of Scrum, DevOps, and test-driven development.
  • Leadership and strategic planning skills.
  • Extensive Salesforce development experience.
  • Experience with Apex Code.
  • Experience with OmniStudio.
  • Salesforce Platform Developer certification.
  • Experience with Visualforce, Flows, Gearset, and Bitbucket.
  • Scalable solution design skills.
  • A bachelor's degree in Computer Science, Information Systems, or another related field.
  • At least 6 years of programming experience, or an equivalent combination of education and experience.
Responsibilities
  • Define architectural guidelines and best practices.
  • Lead software development initiatives from conception to deployment.
  • Collaborate with stakeholders to align software solutions with business objectives.
  • Introduce and train teams in advanced programming languages and tools.
  • Ensure cloud readiness and optimal performance of all applications.
  • Lead and mentor technical and project team members at the business-function level.
  • Lead project teams in analyzing requirements and providing accurate, detailed estimates for design, build, testing, and deployment phases.
  • Provide technical leadership and mentoring to various technical teams.
  • Collaborate with architects, developers, and senior infrastructure technical staff to evaluate and recommend technology advancements and business solutions for assigned projects and applications.
  • Support the implementation and testing of cross-functional systems, ensuring systems meet client and business needs.
  • Provide continuous support to internal and external clients experiencing problems with server hardware, operating systems, core infrastructure applications, and related utilities.
  • Maintain mainframe operating systems or major subsystems and associated software and hardware products, as applicable.
  • Handle unresolved support issues across multiple areas of expertise.
  • Proactively monitor projects, production applications, and core infrastructure to identify improvements to application availability.
  • Analyze current architecture while handling unresolved production support issues.
  • Provide design recommendations and develop application and custom integration solutions, including major enhancements and interfaces.
  • Write complex design specifications.
  • Provide leadership for ongoing maintenance of mainframe and client-server applications or tools, depending on prior project involvement.
  • Facilitate and ensure on-time completion of performance, load, functional, and other testing categories, including application vulnerability testing and issue resolution.
  • Develop new cross-functional software systems using disciplined software development processes.
  • Perform other duties as required.
Desired Qualifications
  • A master's degree in Computer Science, Information Systems, or another related field.

Aflac provides supplemental health and life insurance products to individuals and families, operating mainly in two regions: Aflac Japan and Aflac U.S. Its policies are designed to cover out-of-pocket costs from health events and income loss, including cancer, critical illness, accidents, hospital stays, and life events. These benefits are paid directly to policyholders to help manage medical expenses not fully covered by primary insurance. The products are distributed through a network of independent agents, brokers, and financial advisors, enabling a high-volume, low-premium model that supports a large, stable customer base and ongoing revenue. Japan is its largest market, and the company uses this broad distribution and scale to differentiate itself from competitors. The goal is to provide straightforward financial protection against unexpected health-related costs while expanding its presence in the U.S. and Japanese markets.

Company Size

10,001+

Company Stage

IPO

Headquarters

Columbus, Georgia

Founded

1955

Get referred to Aflac

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Aflac Japan sales rose 7% in first-half 2026, led by Tsumitasu and Anshin Palette.
  • Aflac returned $1.3 billion in Q2 2026 through buybacks and dividends.
  • Maine’s paid-leave program and the Fit Checks campaign expand Aflac’s service reach.

What critics are saying

  • Aflac’s June 2025 breach exposed 22.65 million people and spawned consolidated lawsuits.
  • Japan sales fell 5.6% in Q2 2026 after Miraito comparisons and lapse pressure.
  • Major medical carriers are bundling and discounting supplemental products, eroding Aflac’s moat.

What makes Aflac unique

  • Aflac’s duck brand and agency force still dominate U.S. supplemental insurance.
  • Japan and U.S. businesses diversify earnings across two regulated, cash-generative markets.
  • Aflac sells niche supplemental products, not commodity major-medical coverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Hybrid Work Options

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%
Yahoo Finance
Aug 11th, 2026
Aflac Q2 sales fall 6.9% to $4.22B as Japan product refresh and U.S. group growth offset decline

Aflac reported second-quarter revenue of $4.22 billion, meeting Wall Street expectations but declining 6.9% year on year. Adjusted earnings per share of $1.75 also met analyst estimates. The supplemental insurance provider attributed the revenue decline to tough comparisons in Japan following last year's cancer insurance product launch and shifting consumer preferences. However, CEO Daniel Amos highlighted solid growth from new offerings including Tsumitasu and Anshin Palette. In the US, group voluntary products and network dental and vision sales showed strength, with dental and vision product sales rising 47%. The company maintained expense discipline despite inflationary pressures. Looking ahead, Aflac plans to focus on product innovation in Japan, continued US group product momentum, and enhanced capital management. Management emphasised its commitment to dividend growth and share repurchases.

Yahoo Finance
Aug 6th, 2026
Aflac misses Q2 revenue estimates as sales fall 9.2% to $4.12B

Aflac reported second-quarter revenue of $4.12 billion, missing analyst estimates of $4.23 billion and marking a 9.2% year-on-year decline. The supplemental insurance provider's adjusted earnings per share of $1.75 met expectations. The company's book value per share reached $60.35, beating estimates by 9.3% and showing 18.7% year-on-year growth. Pre-tax profit was $995 million, with a 24.2% margin. Chairman and CEO Daniel P. Amos highlighted solid earnings execution and new opportunities in Japan through products including Anshin Palette medical insurance and Miraito cancer insurance. In the US, Aflac is focusing on supplemental health products for employers. Over the past five years, Aflac's revenue has declined at a 5.1% annual rate, reflecting ongoing demand challenges.

PR Newswire
Aug 6th, 2026
Aflac reports Q2 net earnings of $825M, declares $0.61 quarterly dividend

Aflac Incorporated reported second quarter 2026 results with net earnings of $825 million, or $1.63 per diluted share, compared with $599 million, or $1.11 per diluted share a year ago. Total revenues decreased 1.0% to $4.1 billion. Adjusted earnings were $883 million, down 7.7% from $957 million in the prior year quarter. Adjusted earnings per diluted share decreased 1.7% to $1.75. The company returned $1.3 billion to shareholders through $983 million in share repurchases and $309 million in dividends. Chairman and CEO Daniel Amos highlighted successful product initiatives in Japan and focus on supplemental health products in the US. The board declared a third quarter dividend of $0.61 per share, payable on 1 September 2026 to shareholders of record on 19 August 2026.

Yahoo Finance
Jul 2nd, 2026
Aflac files omnibus shelf registration and launches Fit Checks cancer screening campaign with Rachel Zoe

Aflac has filed an omnibus shelf registration statement covering common stock, debt securities, warrants and other instruments, whilst launching its Fit Checks cancer screening awareness campaign with fashion designer Rachel Zoe. The campaign uses QR-enabled fashion pieces to link wearable design with cancer risk education. The moves demonstrate Aflac's strategy of combining capital markets flexibility with brand-building in preventive health. However, the initiatives don't materially change near-term earnings catalysts or key risks including declining Japanese premiums, currency volatility and investment income pressure. The company's second quarter 2026 earnings release, scheduled for 6-7 August, will provide insight into whether new products and digital initiatives are improving premium trends and margins in Japan and the US, Aflac's primary markets.

Yahoo Finance
May 21st, 2026
Aflac sells $441M bond in Japan as foreign issuers chase low funding costs

US insurer Aflac has sold a ¥65.9 billion ($415 million) yen bond across four tranches, with the 10-year tenor carrying a 3.482% coupon. The offering follows similar moves by foreign issuers including Alphabet and Berkshire Hathaway tapping Japan's credit market. The issuance marks a continuation of Aflac's regular yen bond programme, though the amount was below last year's ¥74.9 billion. Foreign borrowers are capitalising on relatively low funding costs in Japan, benefiting from the wide gap between US and Japanese interest rates. Yen bond issuance by overseas borrowers has surged more than 250% this year to approximately ¥1.6 trillion as of 20 May, compared to the same period in 2025, according to Bloomberg data.